Literature DB >> 20619709

Effect of antiepileptic drugs and reactive oxygen species on folate receptor 1 (FOLR1)-dependent 5-methyltetrahydrofolate transport.

Thomas Opladen1, Nenad Blau, Vincent Th Ramaekers.   

Abstract

Metabolic breakdown of valproate (VPA), carbamazepine (CBZ) and phenytoin (PHT) by the cytochrome P450 pathway generates toxic drug intermediates and reactive oxygen species (ROS). This mechanism has been suspected to play a role in the pathogenesis of secondary cerebral folate deficiency (CFD). Using KB-cell cultures, highly expressing the folate receptor 1 (FOLR1), the effect of antiepileptic drugs (AEDs) and reactive oxygen species (ROS) on the FOLR1 dependent 5-methyltetrahydrofolate (MTHF) uptake was studied. MTHF uptake is time and concentration dependent and shows saturation kinetics. At physiological MTHF concentrations the high-affinity FOLR1 represents the predominant mechanism for cellular incorporation, while at high MTHF concentrations other transport mechanisms participate in folate uptake. Exposure to PHT for more than 8h led to a higher MTHF uptake and decreased cell count, whereas MTHF uptake remained unaltered by VPA and CBZ. However, exposure to superoxide and hydrogen peroxide radicals significantly decreased cellular MTHF uptake. By specific elimination and downregulation of FOLR1 using phosphatidyl-inositol-specific phospholipase C (PIPLC) and siRNA silencing, it was shown that ROS not only inhibited FOLR1 mediated MTHF uptake but also affected all other mechanisms of membrane-mediated MTHF uptake. Generation of ROS with the use of AED might therefore provide an additional explanation for the disturbed folate transfer across the blood-CSF barrier in patients with CFD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619709     DOI: 10.1016/j.ymgme.2010.05.006

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  7 in total

1.  Effect of Folic Acid Supplementation on Seizure Control in Epileptic Children Receiving Long Term Antiepileptic Therapy.

Authors:  Bindu Deopa; Manish Parakh; Pawan Dara; Vikas Payal; Kapil Chordiya; Ankit Panday; Sumeet Singh; Devesh Parashar
Journal:  Indian J Pediatr       Date:  2018-01-25       Impact factor: 1.967

2.  Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene.

Authors:  Belén Pérez-Dueñas; Claudio Toma; Aida Ormazábal; Jordi Muchart; Francesc Sanmartí; Georgina Bombau; Mercedes Serrano; Angels García-Cazorla; Bru Cormand; Rafael Artuch
Journal:  J Inherit Metab Dis       Date:  2010-09-21       Impact factor: 4.982

3.  Oxidative Stress, Folate Receptor Autoimmunity, and CSF Findings in Severe Infantile Autism.

Authors:  Vincent T Ramaekers; Jeffrey M Sequeira; Beat Thöny; Edward V Quadros
Journal:  Autism Res Treat       Date:  2020-11-18

Review 4.  Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis.

Authors:  R S Brown; P R Arany
Journal:  Oral Dis       Date:  2014-08-07       Impact factor: 3.511

5.  Improving Outcome in Infantile Autism with Folate Receptor Autoimmunity and Nutritional Derangements: A Self-Controlled Trial.

Authors:  Vincent Th Ramaekers; Jeffrey M Sequeira; Marco DiDuca; Géraldine Vrancken; Aurore Thomas; Céline Philippe; Marie Peters; Annick Jadot; Edward V Quadros
Journal:  Autism Res Treat       Date:  2019-06-18

Review 6.  Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis.

Authors:  Daniel A Rossignol; Richard E Frye
Journal:  J Pers Med       Date:  2021-11-03

Review 7.  Cerebral Folate Deficiency Syndrome: Early Diagnosis, Intervention and Treatment Strategies.

Authors:  Vincent Th Ramaekers; Edward V Quadros
Journal:  Nutrients       Date:  2022-07-28       Impact factor: 6.706

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.